PerpEquities

Equity · Financial services

CME Group (CME) perpetual futures

CME perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade CMEUSDT.

CME Group Inc. operates international marketplaces for futures and options trading, offering clearing, market data, and risk management services to a global client base.

$278.03+1.8%NASDAQ closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · Helix (Injective) (CME/USDC)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/2 live markets
Venues
2
Live markets
1/2
24h volume
$65.4
Open interest
-Coverage: 0/1 markets
Best liquidity
-
Tightest spread
-
Highest volume
$65.4
Helix (Injective)
Settlement mix
USDC · 1/2
Perp/spot vol.
0.00x
Spot volume $931.8M
OI / float
-
Float $98.6B
Spot performance
1D+1.79%
5D-1.35%
1M+1.90%
6M-10.19%
YTD+1.07%
1Y+5.72%

Venue matrix

2 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
Helix (Injective)TradeCME/USDCTrading$278.03+24.1% APR
+0.00275% every 1h
--$65.4-USDC12x
BingXTradeCMEUS-USDTWatchlist------USDT-

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 1 venues absorb $10k

No fresh book data: Helix (Injective)

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

-
No live data-

Tightest spread

-
No live data-

Highest volume

CME

Funding history

Stored venue snapshots by market

Company data

Company fundamentals

Updated 3h ago
Market cap
$99.2B
Updated 3h ago
Revenue
$6.8B
Trailing 12 months
Revenue growth
+8%
Next fiscal year
Profit margin
+63.1%
P/E
23.3
Peer P/E 26.2
Free cash flow
$4.2B
Trailing 12 months
More metrics
Net income
$4.3B
Trailing 12 months
P/S
14.7
Peer P/E
26.2
Similar listed perps
Revenue estimate
$7B
Next fiscal year
Earnings
2026-10-21
Revenue est. $1.7B · Updated 3h ago
Dividend
$1.3
2026-09-09

Fundamental detail

Annual + quarterly
Latest revenue$6.5B
Net margin+62.0%
Free cash flow$4.2B
Net debt-$666.2M
2020$4.9B
2021$4.7B
2022$5B
2023$5.6B
2024$6.1B
2025$6.5B
PeriodRevenueGrowthNet incomeFCF
2020$4.9B0%$2.1B$2.5B
2021$4.7B-4%$2.6B$2.3B
2022$5B+7%$2.7B$3B
2023$5.6B+11%$3.2B$3.4B
2024$6.1B+10%$3.5B$3.6B
2025$6.5B+6%$4B$4.2B
PeriodGross marginOperating marginNet marginROEROA
2020+82.5%+54.0%+43.1%+8.0%+1.7%
2021+82.2%+56.4%+56.2%+9.6%+1.3%
2022+85.0%+60.1%+53.6%+10.0%+1.5%
2023+85.1%+61.6%+57.8%+12.1%+2.5%
2024+86.1%+64.1%+57.5%+13.3%+2.6%
2025+86.1%+64.9%+62.0%+14.1%+2.0%
PeriodCashDebtNet debtCurrent ratio
2020$1.6B$3.4B$1.8B1.01
2021$2.8B$3.4B$610.2M1.01
2022$2.7B$3.4B$718.3M1.01
2023$2.9B$3.4B$513.4M1.02
2024$2.9B$3.4B$535.6M1.01
2025$4.4B$3.8B-$666.2M92.97
PeriodMarket capEnterprise valueP/SP/E
2020$65.1B$66.9B13.331.0
2021$81.9B$82.5B17.531.3
2022$60.3B$61B12.022.7
2023$75.6B$76.1B13.623.7
2024$83.5B$84B13.624.0
2025$98.2B$97.5B15.124.4
Q3 2024$1.6B
Q4 2024$1.5B
Q1 2025$1.6B
Q2 2025$1.7B
Q3 2025$1.5B
Q4 2025$1.6B
Q1 2026$1.9B
Q2 2026$1.7B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$1.6B+18%$912.8M$973.2M
Q4 2024$1.5B+6%$874.6M$991.7M
Q1 2025$1.6B+10%$956.2M$1.1B
Q2 2025$1.7B+10%$1B$1B
Q3 2025$1.5B-3%$908M$949.7M
Q4 2025$1.6B+8%$1.2B$1.1B
Q1 2026$1.9B+14%$1.2B$1.2B
Q2 2026$1.7B+1%$1B$923.5M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+86.2%+64.6%+57.6%+3.2%+0.7%
Q4 2024+85.5%+62.1%+57.3%+3.3%+0.6%
Q1 2025+87.4%+67.5%+58.2%+3.5%+0.6%
Q2 2025+86.9%+66.7%+59.8%+3.6%+0.6%
Q3 2025+84.5%+63.3%+59.1%+3.2%+0.5%
Q4 2025+85.4%+61.8%+70.8%+4.1%+0.6%
Q1 2026+88.1%+69.7%+61.4%+4.3%+0.6%
Q2 2026+69.2%+64.9%+61.1%+3.9%+0.5%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$2.3B$3.4B$1.1B1.02
Q4 2024$2.9B$3.4B$535.6M1.01
Q1 2025$1.4B$3.4B$2B1.02
Q2 2025$2B$3.4B$1.4B1.02
Q3 2025$2.4B$3.4B$974.5M1.02
Q4 2025$4.4B$3.8B-$666.2M92.97
Q1 2026$2.4B$3.4B$1B1.02
Q2 2026$2.1B$3.4B$1.3B1.02
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$79.3B$80.4B50.122.0
Q4 2024$83.5B$84B54.724.2
Q1 2025$95.4B$97.4B58.125.2
Q2 2025$99.1B$100.6B58.624.5
Q3 2025$97.2B$98.1B63.227.1
Q4 2025$98.2B$97.5B59.621.0
Q1 2026$106.1B$107.2B56.422.7
Q2 2026$79.5B$80.8B46.619.3

Refreshed 3h ago

Charts: revenue, profit, cash flow & valuation
Revenue$1.7BQ2 2026
$470M$940.1M$1.4B$1.9BQ3 2023: $1.3BQ4 2023: $1.4BQ1 2024: $1.5BQ2 2024: $1.5BQ3 2024: $1.6BQ4 2024: $1.5BQ1 2025: $1.6BQ2 2025: $1.7BQ3 2025: $1.5BQ4 2025: $1.6BQ1 2026: $1.9BQ2 2026: $1.7BQ3 2023Q2 2026
Net income$1BQ2 2026
$292M$584M$876M$1.2BQ3 2023: $750.2MQ4 2023: $814.6MQ1 2024: $855.2MQ2 2024: $883.2MQ3 2024: $912.8MQ4 2024: $874.6MQ1 2025: $956.2MQ2 2025: $1BQ3 2025: $908MQ4 2025: $1.2BQ1 2026: $1.2BQ2 2026: $1BQ3 2023Q2 2026
EBITDA$834.4MQ2 2026
$409.5M$818.9M$1.2B$1.6BQ3 2023: $1.1BQ4 2023: $1.1BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.2BQ1 2025: $1.4BQ2 2025: $1.5BQ3 2025: $1.3BQ4 2025: $1.6BQ1 2026: $1.6BQ2 2026: $834.4MQ3 2023Q2 2026
Free cash flow$923.5MQ2 2026
$309.5M$619.1M$928.6M$1.2BQ3 2023: $836.8MQ4 2023: $1BQ1 2024: $872.9MQ2 2024: $758.7MQ3 2024: $973.2MQ4 2024: $991.7MQ1 2025: $1.1BQ2 2025: $1BQ3 2025: $949.7MQ4 2025: $1.1BQ1 2026: $1.2BQ2 2026: $923.5MQ3 2023Q2 2026
EPS$2.88Q2 2026
$0.81$1.62$2.43$3.24Q3 2023: $2.06Q4 2023: $2.24Q1 2024: $2.35Q2 2024: $2.42Q3 2024: $2.5Q4 2024: $2.4Q1 2025: $2.62Q2 2025: $2.81Q3 2025: $2.49Q4 2025: $3.24Q1 2026: $3.18Q2 2026: $2.88Q3 2023Q2 2026
Cash / Debt$2.1BQ2 2026
$1.1B$2.2B$3.3B$4.4BQ3 2023 · Cash: $2.3BQ3 2023 · Debt: $3.4BQ4 2023 · Cash: $2.9BQ4 2023 · Debt: $3.4BQ1 2024 · Cash: $1.4BQ1 2024 · Debt: $3.4BQ2 2024 · Cash: $1.8BQ2 2024 · Debt: $3.4BQ3 2024 · Cash: $2.3BQ3 2024 · Debt: $3.4BQ4 2024 · Cash: $2.9BQ4 2024 · Debt: $3.4BQ1 2025 · Cash: $1.4BQ1 2025 · Debt: $3.4BQ2 2025 · Cash: $2BQ2 2025 · Debt: $3.4BQ3 2025 · Cash: $2.4BQ3 2025 · Debt: $3.4BQ4 2025 · Cash: $4.4BQ4 2025 · Debt: $3.8BQ1 2026 · Cash: $2.4BQ1 2026 · Debt: $3.4BQ2 2026 · Cash: $2.1BQ2 2026 · Debt: $3.4BQ3 2023Q2 2026
CashDebt
Profitability+69.2%Q2 2026
+22.0%+44.1%+66.1%+88.1%Q3 2023 · Gross margin: +84.6%Q4 2023 · Gross margin: +85.2%Q1 2024 · Gross margin: +86.2%Q2 2024 · Gross margin: +86.6%Q3 2024 · Gross margin: +86.2%Q4 2024 · Gross margin: +85.5%Q1 2025 · Gross margin: +87.4%Q2 2025 · Gross margin: +86.9%Q3 2025 · Gross margin: +84.5%Q4 2025 · Gross margin: +85.4%Q1 2026 · Gross margin: +88.1%Q2 2026 · Gross margin: +69.2%Q3 2023 · Operating margin: +61.3%Q4 2023 · Operating margin: +60.0%Q1 2024 · Operating margin: +64.5%Q2 2024 · Operating margin: +65.3%Q3 2024 · Operating margin: +64.6%Q4 2024 · Operating margin: +62.1%Q1 2025 · Operating margin: +67.5%Q2 2025 · Operating margin: +66.7%Q3 2025 · Operating margin: +63.3%Q4 2025 · Operating margin: +61.8%Q1 2026 · Operating margin: +69.7%Q2 2026 · Operating margin: +64.9%Q3 2023 · Net margin: +56.1%Q4 2023 · Net margin: +56.6%Q1 2024 · Net margin: +57.5%Q2 2024 · Net margin: +57.6%Q3 2024 · Net margin: +57.6%Q4 2024 · Net margin: +57.3%Q1 2025 · Net margin: +58.2%Q2 2025 · Net margin: +59.8%Q3 2025 · Net margin: +59.1%Q4 2025 · Net margin: +70.8%Q1 2026 · Net margin: +61.4%Q2 2026 · Net margin: +61.1%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+0.8%Q2 2026
+2.4%+7.7%+13.1%+18.4%Q3 2024: +18.4%Q4 2024: +6.0%Q1 2025: +10.4%Q2 2025: +10.4%Q3 2025: -3.0%Q4 2025: +8.1%Q1 2026: +14.5%Q2 2026: +0.8%Q3 2023Q2 2026
Shares outstanding362.2MQ2 2026
90.8M181.6M272.4M363.2MQ3 2023: 359.6MQ4 2023: 359.7MQ1 2024: 359.8MQ2 2024: 359.9MQ3 2024: 360MQ4 2024: 360.1MQ1 2025: 360.2MQ2 2025: 360.3MQ3 2025: 360.3MQ4 2025: 360.2MQ1 2026: 363.2MQ2 2026: 362.2MQ3 2023Q2 2026
Valuation19.3Q2 2026
15.831.647.463.2Q3 2023 · P/E: 24.3Q4 2023 · P/E: 23.5Q1 2024 · P/E: 22.6Q2 2024 · P/E: 20.1Q3 2024 · P/E: 22.0Q4 2024 · P/E: 24.2Q1 2025 · P/E: 25.2Q2 2025 · P/E: 24.5Q3 2025 · P/E: 27.1Q4 2025 · P/E: 21.0Q1 2026 · P/E: 22.7Q2 2026 · P/E: 19.3Q3 2023 · P/S: 53.7Q4 2023 · P/S: 52.6Q1 2024 · P/S: 51.2Q2 2024 · P/S: 45.8Q3 2024 · P/S: 50.1Q4 2024 · P/S: 54.7Q1 2025 · P/S: 58.1Q2 2025 · P/S: 58.6Q3 2025 · P/S: 63.2Q4 2025 · P/S: 59.6Q1 2026 · P/S: 56.4Q2 2026 · P/S: 46.6Q3 2023Q2 2026
P/EP/S
Revenue$6.5B2025
$1.6B$3.3B$4.9B$6.5B2018: $4.3B2019: $4.9B2020: $4.9B2021: $4.7B2022: $5B2023: $5.6B2024: $6.1B2025: $6.5B20182025
Net income$4B2025
$1B$2B$3B$4B2018: $2B2019: $2.1B2020: $2.1B2021: $2.6B2022: $2.7B2023: $3.2B2024: $3.5B2025: $4B20182025
EBITDA$5.7B2025
$1.4B$2.9B$4.3B$5.7B2018: $3.2B2019: $3.3B2020: $3.4B2021: $3.9B2022: $4B2023: $4.7B2024: $5B2025: $5.7B20182025
Free cash flow$4.2B2025
$1B$2.1B$3.1B$4.2B2018: $2.3B2019: $2.4B2020: $2.5B2021: $2.3B2022: $3B2023: $3.4B2024: $3.6B2025: $4.2B20182025
EPS$11.22025
$2.79$5.58$8.37$11.22018: $5.712019: $5.912020: $5.872021: $7.292022: $7.42023: $8.862024: $9.672025: $11.220182025
Cash / Debt$4.4B2025
$1.1B$2.2B$3.3B$4.4B2018 · Cash: $1.4B2018 · Debt: $4.4B2019 · Cash: $1.6B2019 · Debt: $3.7B2020 · Cash: $1.6B2020 · Debt: $3.4B2021 · Cash: $2.8B2021 · Debt: $3.4B2022 · Cash: $2.7B2022 · Debt: $3.4B2023 · Cash: $2.9B2023 · Debt: $3.4B2024 · Cash: $2.9B2024 · Debt: $3.4B2025 · Cash: $4.4B2025 · Debt: $3.8B20182025
CashDebt
Profitability+86.1%2025
+21.5%+43.1%+64.6%+86.1%2018 · Gross margin: +84.4%2019 · Gross margin: +81.5%2020 · Gross margin: +82.5%2021 · Gross margin: +82.2%2022 · Gross margin: +85.0%2023 · Gross margin: +85.1%2024 · Gross margin: +86.1%2025 · Gross margin: +86.1%2018 · Operating margin: +60.5%2019 · Operating margin: +53.2%2020 · Operating margin: +54.0%2021 · Operating margin: +56.4%2022 · Operating margin: +60.1%2023 · Operating margin: +61.6%2024 · Operating margin: +64.1%2025 · Operating margin: +64.9%2018 · Net margin: +45.5%2019 · Net margin: +43.5%2020 · Net margin: +43.1%2021 · Net margin: +56.2%2022 · Net margin: +53.6%2023 · Net margin: +57.8%2024 · Net margin: +57.5%2025 · Net margin: +62.0%20182025
Gross marginOperating marginNet margin
Revenue growth+6.4%2025
+0.3%+4.5%+8.7%+13.0%2019: +13.0%2020: +0.3%2021: -4.0%2022: +7.0%2023: +11.1%2024: +9.9%2025: +6.4%20182025
Shares outstanding360.2M2025
90.1M180.1M270.2M360.2M2018: 343.7M2019: 358.2M2020: 358.5M2021: 358.9M2022: 359.2M2023: 359.5M2024: 359.9M2025: 360.2M20182025
Valuation24.42025
8.516.925.433.82018 · P/E: 32.82019 · P/E: 33.82020 · P/E: 31.02021 · P/E: 31.32022 · P/E: 22.72023 · P/E: 23.72024 · P/E: 24.02025 · P/E: 24.42018 · P/S: 14.92019 · P/S: 14.72020 · P/S: 13.32021 · P/S: 17.52022 · P/S: 12.02023 · P/S: 13.62024 · P/S: 13.62025 · P/S: 15.120182025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-10-21
Revenue est. $1.7B · Updated 3h ago
Dividend
$1.3
2026-09-09

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202612.25$7B+8%10
FY 202712.92$7.4B+13%10
FY 202813.86$7.9B+20%4
FY 202914.99$8.5B+30%1
FY 203016.05$8.7B+34%1
Q1 20293.72$2.1B+10%8

Company events

6
2026-10-21EarningsActual - / Estimate 2.96-
2026-09-09Dividend$1.3-
2026-07-22EarningsActual 2.99 / Estimate 2.91Beat
2026-06-09Dividend$1.3-
2026-04-22EarningsActual 3.36 / Estimate 3.34Beat
2026-03-10Dividend$7.45-

Peer comparison

Similar listed perps

Analyst track record

How the analysts covering CME have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings98304
Analysts1720
Buy / hold / sell35 / 45 / 18109 / 157 / 38
Upgrades / downgrades / initiations7 / 2 / 09 / 12 / 3
Price targets hit / missed22 / 73 (23%)176 / 122 (59%)
Avg. return after a rating (TipRanks)-5.8%+6.9%
Best / worst call+34.9% / -25.1%+56.7% / -25.1%

After buy calls on this stock: median 21-day move +1.6% vs S&P 500 -1.1% (n = 106)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Christopher AllenKBW90% hit rate on this stock · 10 targets measuredBuytarget $285Sep 3, 2026
  2. Alex KrammUBS89% hit rate on this stock · 9 targets measuredHoldtarget $260Sep 3, 2026
  3. Patrick MoleyPiper Sandler87% hit rate on this stock · 15 targets measuredBuytarget $295Jul 23, 2026

Latest ratings

DateAnalystCallTarget
Sep 3, 2026William KatzTD CowenBuyReiterated$292
Sep 3, 2026Alex KrammUBSHoldReiterated$260
Sep 3, 2026Christopher AllenKBWBuyMaintained$285
Aug 19, 2026Brian BedellDeutsche BankHoldDowngraded$270
Aug 5, 2026Benjamin BudishBarclaysHoldMaintained$270
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$220$240$260$280$300$320Oct 25 · Buy 8 · Hold 5 · Sell 2Oct 25Nov 25 · Buy 8 · Hold 4 · Sell 2Dec 25 · Buy 8 · Hold 4 · Sell 2Dec 25Jan 26 · Buy 7 · Hold 4 · Sell 2Feb 26 · Buy 7 · Hold 4 · Sell 2Feb 26Mar 26 · Buy 6 · Hold 5 · Sell 3Apr 26 · Buy 4 · Hold 5 · Sell 3Apr 26May 26 · Buy 4 · Hold 5 · Sell 3Jun 26 · Buy 5 · Hold 5 · Sell 3Jun 26Jul 26 · Buy 6 · Hold 5 · Sell 3Aug 26 · Buy 6 · Hold 5 · Sell 3Aug 26Sep 26 · Buy 6 · Hold 5 · Sell 3Oct 25 · avg. target $287Nov 25 · avg. target $288Dec 25 · avg. target $292Jan 26 · avg. target $290Feb 26 · avg. target $299Mar 26 · avg. target $298Apr 26 · avg. target $304May 26 · avg. target $304Jun 26 · avg. target $298Jul 26 · avg. target $279Aug 26 · avg. target $278Sep 26 · avg. target $280Oct 25 · month-end close $265Nov 25 · month-end close $281Dec 25 · month-end close $273Jan 26 · month-end close $289Feb 26 · month-end close $320Mar 26 · month-end close $295Apr 26 · month-end close $288May 26 · month-end close $274Jun 26 · month-end close $221Jul 26 · month-end close $268Aug 26 · month-end close $286Sep 26 · month-end close $271

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 18, 2026 · 98 ratings

Frequently asked questions

Where can I trade CME perpetual futures?

CME Group (CME) perpetual futures trade on 1 crypto venues, including Helix (Injective). PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade CME around the clock?

Yes. Unlike the underlying stock, CME perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on CME perpetuals?

Right now the CME perp funding rate is +24.1% annualized (venue median), ranging from +24.1% to +24.1% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the CME perp price compare to the CME Group stock?

The venue-median CME perp mark is $278 versus a reference stock price of $278, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a CME perpetual future?

A CME perpetual is a derivative that tracks the price of CME Group with no expiry date. It lets you take long or short exposure to CME Group on crypto venues, around the clock.

What is CMEUSDT perpetual?

CMEUSDT is the symbol most crypto exchanges use for the CME Group perpetual settled in USDT (Tether). It tracks the CME share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

CME perpetuals · perpequities.comCME perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/cme-perp"><img src="https://perpequities.com/badge/cme-perp.svg" width="240" height="64" alt="CME perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of CME perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for CME — one email every Sunday.

Watchlist and alerts

Price and funding alerts for CME, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X